Italia markets close in 5 hours 56 minutes

T2 Biosystems, Inc. (0A57.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,9300+0,0300 (+1,03%)
In data: 06:55PM BST. Mercato aperto.
Schermo intero
Chiusura precedente2,9000
Aperto0,0000
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno0,0000 - 0,0000
Intervallo di 52 settimane
Volume4.066
Media Volume1.849
CapitalizzazioneN/D
Beta (5 anni mensile)0,10
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utili21 mag 2024 - 28 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates

    Received FDA 510(k) clearance for the T2Biothreat Panel and significantly strengthened balance sheetLEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial results for the third quarter ended September 30, 2023 and business updates. Recent Financial and Operational Highlights Achieved preliminary third quarter

  • GlobeNewswire

    T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii

    LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) to expand the number of pathogens detected on the FDA-cleared T2Bacteria® Panel to include the detection of Acinetobacter baumannii (A. baumannii). A. baumannii is a cause of bloodstream infections espec

  • GlobeNewswire

    T2 Biosystems Announces Reverse Stock Split Effective Today

    TTOO common stock expected to begin trading on a split-adjusted basis on October 13, 2023LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Company’s board of directors (the “Board”) has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares. The reverse stock split wil